PPT-Glycemic Management in Type 2 Diabetes
Author : natalia-silvester | Published Date : 2017-08-07
Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004 1 P lt0001 vs active comparator monotherapy P lt0001 vs active comparator dual therapy
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Glycemic Management in Type 2 Diabetes" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Glycemic Management in Type 2 Diabetes: Transcript
Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004 1 P lt0001 vs active comparator monotherapy P lt0001 vs active comparator dual therapy 1 Nauck MA et al . Pharmacologic Management of Type 2 . Diabetes . Chapter 13. (Updated July 2015). William Harper, Maureen Clement, Ronald Goldenberg,. Amir Hanna, Andrea Main, . Ravi . Retnakaran. , . Diana . Sherifali,Vincent. 1. AACE Comprehensive Care Plan. 2. Handelsman Y, et al. . Endocr Pract. . 2011;17(suppl 2):1-53.. Glycemic Management in Type 2 Diabetes. Therapeutic Lifestyle Change. 3. Components of Therapeutic Lifestyle Change. 1c. Goals: Applying Guidelines to Intensify Therapy in Patients With Diabetes. Goals. HbA. 1c. Targets: HEDIS and ADA. Objectives for Treatment of T2D. ADA/EASD Recommendations for HbA. 1c. Approach for Individualizing Glycemic Targets. Efficacy and Safety of Antihyperglycemic Therapies Introduced Since 2004. 1. DPP-4 Inhibitors. 2. FDA-Approved Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key Features. Oral administration. Efficacy and Safety of Modern Antihyperglycemic Therapies. 1. DPP-4 Inhibitors. 2. DPP-4 Inhibitors. FDA-Approved . Agents. Alogliptin. Linagliptin. Saxagliptin. Sitagliptin. Key . Features. Oral administration. 1. AACE Comprehensive Care Plan. Handelsman YH, et al. . Endocr Pract. . 2015;21(suppl 1):1-87.. 2. Therapeutic Lifestyle Change. Glycemic Management of Type 2 Diabetes. 3. Components of Therapeutic Lifestyle Change. Help patients with type 2 diabetes achieve their glycemic goals. 1. In the US, diabetes is the primary diagnosis for . 37 million visits. to a physician’s office, emergency department or outpatient hospital-based clinic . National Center for Health in Public Housing Clinical Quality Working Group. Diabetes in PHPC Settings. HBA1c>9 in PHPC Settings. American Diabetes Association’s Press Release. The ADA has long recommended that treatment goals be individualized based on factors both modifiable and nonmodifiable, such as age, life expectancy, duration of disease, resources and support, and comorbid conditions. The ADA recommends that a reasonable A1C goal for many nonpregnant adults with type 2 diabetes is less than 7 percent based on the available evidence to date from the ACCORD, ADVANCE, VADT and UKPDS international clinical trials, which were evaluated and incorporated into ADA’s Standards of Care. . A Network Meta-Analysis. Vanessa Ha, PhD Student. Supervisors: Drs. Sonia . Anand. and Russell de Souza. Complications of Gestational Diabetes Mellitus. High blood pressure. &. pre-eclampsia. Type 2 diabetes. INTRODUCTION The concept of the glycemic index (GI) wasintroduced as a means of classifying carbohydrate containingfoods based on the blood glucose response after food consump-tion. The GI is define : Long-term hyperglycemia promotes development of complications and suboptimal well-being in patients with diabetes. A stringent glycemic control is a worldwide standard of diabetes care recommended i Type II and Pre Diabetes Eat Right 4 Your Type | Featuring brandnew targeted food and supplement lists specific to diabetes that readers wont find anywhere elseAmericas fastestgrowing health problem just got dealt a major blow Dr Peter J DAdamo the creator of the Blood Type Diet which has forever c for HCSWs. Katharine Ramage. Diabetes MCN Professional Education Lead/DSN. Learning Outcomes. Develop an understanding of the different types of diabetes, risk factors for developing diabetes, how it can present and how it is diagnosed. ●. . Section . was . renamed. ●. . . N. ew recommendation. : . using . reliable data . metrics. ●. . . D. iscussion on . the social determinants of . health. ●. . . Te. lemedicine role.
Download Document
Here is the link to download the presentation.
"Glycemic Management in Type 2 Diabetes"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents